Role of α1‐blockers in the current management of hypertension

Strain Imaging for the Early Detection of Cardiac Remodeling and Dysfunction in Primary Aldosteronism

(2022) Yilin Chen et al.   Diagnostics

Alpha Blocker-Associated Intraoperative Floppy Iris Syndrome

(2022) Maha Saad et al.   Senior Care Pharmacist

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature

(2021) Rawan M. Alnazer et al.   Journal of Clinical Hypertension

China nationwide screening and registry of primary aldosteronism in hypertensive patients

(2021) Xin Chen et al.   JOURNAL OF HUMAN HYPERTENSION

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2021) Theresa A McDonagh et al.   EUROPEAN HEART JOURNAL

A non-invasive left ventricular pressure-strain loop study on myocardial work in primary aldosteronism

(2021) Yi-Lin Chen et al.   HYPERTENSION RESEARCH

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management

(2021) Lori B. Lerner et al.   JOURNAL OF UROLOGY

A speckle tracking echocardiographic study on right ventricular function in primary aldosteronism

(2020) Yi-Lin Chen et al.   JOURNAL OF HYPERTENSION

Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study

(2020) Gregory L. Hundemer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Resistant Hypertension in Chronic Kidney Disease (CKD): Prevalence, Treatment Particularities, and Research Agenda

(2020) Panagiotis I. Georgianos et al.   CURRENT HYPERTENSION REPORTS

Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography

(2019) Dian Wang et al.   JOURNAL OF HYPERTENSION

Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study

(2019) Weiyu Zhang et al.   BMJ Open

Status of Hypertension in China

(2018) Zengwu Wang et al.   CIRCULATION

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

(2018) Bryan Williams et al.   Lancet Diabetes & Endocrinology

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

(2018) Silvia Monticone et al.   Lancet Diabetes & Endocrinology

Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism

(2018) Dian Wang et al.   AMERICAN JOURNAL OF HYPERTENSION

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   JOURNAL OF HYPERTENSION

Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure

(2018) Cynthia A. Jackevicius et al.   JACC-Heart Failure

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia

(2017) Yukio Homma et al.   INTERNATIONAL JOURNAL OF UROLOGY

Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice

(2017) Silvia Monticone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis

(2016) Sabine C. Käyser et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

(2016) John W. Funder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008

(2015) K. B. Egan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive Populations

(2014) Dmitrij Achelrod et al.   AMERICAN JOURNAL OF HYPERTENSION

Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study

(2014) Yook Chin Chia et al.   BMC Family Practice

Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension

(2013) Aleksander Prejbisz et al.   Endokrynologia Polska

Prevalence, awareness, treatment and control of hypertension in elderly Chinese

(2013) Chang-Sheng Sheng et al.   HYPERTENSION RESEARCH

Prevalence of Resistant Hypertension in the United States, 2003–2008

(2011) Stephen D. Persell   HYPERTENSION

Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin

(2011) Satoshi Hoshide et al.   HYPERTENSION RESEARCH

Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study

(2011) M. S. Chung et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Q: Should alpha-blockers ever be used as antihypertensive drugs?

(2010) G. ROSSITTO et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?

(2010) Neil Chapman et al.   JOURNAL OF HYPERTENSION

Impact of Alpha 1-Adrenergic Antagonist Use for Benign Prostatic Hypertrophy on Outcomes in Patients With Heart Failure

(2009) Amandeep S. Dhaliwal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial

(2008) Neil Chapman et al.   CIRCULATION